CollabRx and OncoDNA Partner in Molecular Diagnostics

CollabRx, Inc, a data analytics company focused on informing clinical decision making in molecular medicine, and OncoDNA, SA, a Belgium company that provides DNA next generation sequencing (NGS) tests for clinical use in cancer, today announced a multi-year agreement to purchase CollabRx SaaS-based technology and content resources to be used in conjunction with OncoDNA’s cancer mutation panels. Read more











Eric Franzon
VP Community
Jennifer Zaino
Contributor
Angela Guess Contributor
semanticweb.com Twitter feed loading...